Alliancebernstein L.P. Eloxx Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$1.35 - $3.36 $28,485 - $70,896	-21,100 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$3.02 - $4.54 $6,040 - $9,080	-2,000 Reduced 8.66%	21,100 $70,000
Q3 2020 Nov 12, 2020	SELL	$2.53 - $3.4 $5,060 - $6,800	-2,000 Reduced 7.97%	23,100 $61,000
Q2 2020 Aug 13, 2020	BUY	$1.56 - $3.65 $5,772 - $13,505	3,700 Added 17.29%	25,100 $76,000
Q1 2020 May 14, 2020	BUY	$1.96 - $7.96 $2,744 - $11,144	1,400 Added 7.0%	21,400 $42,000
Q3 2019 Nov 14, 2019	BUY	$4.37 - $9.91 $11,799 - $26,757	2,700 Added 15.61%	20,000 $90,000
Q2 2019 Aug 14, 2019	BUY	$8.77 - $12.49 $37,711 - $53,707	4,300 Added 33.08%	17,300 $172,000
Q1 2019 May 14, 2019	BUY	$10.45 - $13.94 $135,850 - $181,220	13,000 New	13,000 $152,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.